ClinicalTrials.Veeva
Menu

Find clinical trials for Kidney Disease in Aurora, CO

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Kidney Diseases
Chronic Renal Insufficiency
Chronic Kidney Failure
IGA Glomerulonephritis
Renal Insufficiency
Renal Cell Carcinoma
Kidney Cancer

Kidney Disease trials near Aurora, CO, USA:

A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis

This is a phase 3 trial of etelcalcetide in pediatric participants with secondary hyperparathyroidism (SHPT) and chronic kidney disease...

Enrolling
Chronic Kidney Disease
Secondary Hyperparathyroidism
Other: Standard of Care
Drug: Etelcalcetide

Phase 3

Amgen
Amgen

Aurora, Colorado, United States and 43 other locations

Powerful new drugs that can prevent or delay end stage kidney disease (ESKD) - so called sodium-glucose cotransporter-2 inhibitors ...

Enrolling
Kidney Failure, Chronic
Diabetic Nephropathies
Drug: Placebo
Drug: Sotagliflozin

Phase 3

Alessandro Doria

Aurora, Colorado, United States and 18 other locations

to evaluate efficacy, safety and tolerability of treatment with zibotentan/dapagliflozin and dapagliflozin alone in participants with chronic kidney...

Active, not recruiting
Chronic Kidney Disease With High Proteinuria
Drug: Dapagliflozin
Drug: Zibotentan/Dapagliflozin

Phase 3

AstraZeneca
AstraZeneca

Denver, Colorado, United States and 297 other locations

Recently updated

We are doing this study to learn more about how tirzepatide may help fight chronic kidney disease in people with obesity with or wi...

Active, not recruiting
Chronic Kidney Disease
Overweight
Drug: Placebo
Drug: Tirzepatide

Phase 2

Lilly
Lilly

Aurora, Colorado, United States and 26 other locations

The study evaluates the safety of different doses of a new medicine called NNC0519 0130. It also looks into how the medicine may improve kidney...

Enrolling
Chronic Kidney Disease
Drug: Placebo
Drug: Semaglutide

Phase 2

Novo Nordisk
Novo Nordisk

Aurora, Colorado, United States and 135 other locations

to healthy participants (Phase I) or participants with end-stage kidney disease receiving hemodialysis through a central venous cat...

Enrolling
Staphylococcus Aureus
Drug: AZD7760
Other: Placebo

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Englewood, Colorado, United States and 41 other locations

and Tolerability of Baxdrostat in combination with Dapagliflozin on renal outcomes and cardiovascular mortality in participants with chronic kidney...

Enrolling
Chronic Kidney Disease and Hypertension
Drug: Baxdrostat/dapagliflozin
Drug: Placebo/dapagliflozin

Phase 3

AstraZeneca
AstraZeneca

Denver, Colorado, United States and 744 other locations

The primary objective of this study is to assess the efficacy of a single dose of ravulizumab IV compared with placebo in reducing the risk of the cl...

Active, not recruiting
Chronic Kidney Disease
Cardiac Disease
Drug: Placebo
Drug: Ravulizumab

Phase 3

Alexion Pharmaceuticals
Alexion Pharmaceuticals

Aurora, Colorado, United States and 161 other locations

This study is open to adults with certain kidney conditions, including secondary focal segmental glomerulosclerosis (sFSGS), treatment-resis...

Enrolling
Proteinuric Kidney Diseases
Drug: Placebo matching BI 764198
Drug: BI 764198

Phase 2

Boehringer Ingelheim
Boehringer Ingelheim

Denver, Colorado, United States and 146 other locations

and pharmacodynamics of WAL0921 in subjects with glomerular kidney disease and proteinuria, including diabetic nephropathy and rare ...

Enrolling
Minimal Change Disease
Diabetic Nephropathies
Drug: WAL0921
Drug: Placebo

Phase 2

Walden Biosciences

Denver, Colorado, United States and 49 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems